Effectiveness of lurasidone 80 mg in patients with schizophrenia: Results of an open-label, I2-week extension study.

Authors
Category Primary study
JournalNeuropsychiatric Disease and Treatment
Year 2022
This article has no abstract
Epistemonikos ID: 3c1c4902b910091b50fafabc599b4c309febb2db
First added on: Feb 15, 2025